Group 1: Share Transfer and Control Changes - The share transfer agreement between Lu Nan and Cangnan Investment has been signed, pending regulatory approval and compliance confirmation from the Shenzhen Stock Exchange. After completion, Cangnan Finance Bureau will hold a total of 11.33% of the company's shares, becoming the actual controller [1][4] - The company is committed to timely disclosure of any necessary information as per regulatory requirements [1] Group 2: Future Development Strategy - The company focuses on "IoT-centric growth" as its core strategy for the next three years, aiming to enhance its IoT business and reduce its medical business operations [2][3] - The goal is to establish itself as a leading enterprise in the domestic RFID industry chain, with increased resource investment in IoT applications across various sectors [2] Group 3: Financial Performance - In 2024, the company's commercial intelligence business generated revenue of 500.80 million yuan, accounting for 72.50% of total revenue, while the smart medical business generated 170.31 million yuan, accounting for 24.66% [3] - The sale of medical technology assets was driven by significant revenue decline and continuous losses in the smart medical sector, allowing the company to focus on its core commercial intelligence business [3][4] Group 4: Strategic Partnerships - The strategic cooperation with Cangnan government aims to enhance long-term collaboration in the smart business sector, leveraging shared resources for mutual growth [3] Group 5: Recent Financial Transactions - The sale of medical technology assets generated 562 million yuan, with 304 million yuan recorded as other business income and 11.21 million yuan as asset disposal gains in Q1 2025 [4]

Group 1 - The event "AI + New Traditional Chinese Medicine Technology Free Health Training and Chronic Disease Risk Screening" aims to enhance community residents' health awareness and self-care abilities [1] - The initiative is a collaboration between Dongguan Community and Zhongjing Second Community Health Service Center, focusing on early detection and intervention of severe health risks such as myocardial infarction and cerebral infarction [1][5] - Since the launch on April 19, a total of 389 residents have participated in the screening, with health risk reports sent to participants' mobile phones in real-time [5] Group 2 - Medical experts conducted engaging health knowledge lectures covering disease prevention, dietary recommendations, and exercise methods, emphasizing the importance of lifestyle habits [3] - The community offers various screening projects, including non-invasive AI retinal imaging for detecting risks of heart and brain diseases, diabetes, and dementia, as well as specialized checks for high-risk groups [3] - The community leader stated the commitment to continue such activities to enhance chronic disease prevention awareness and contribute to building a healthy community [5]

Group 1 - The annual general meeting of shareholders for Jianerkang Medical Technology Co., Ltd. was held on May 13, 2025, at the company's office in Changzhou, Jiangsu Province [2] - All resolutions presented at the meeting were approved without any objections [2] - The meeting was attended by all nine current directors, three supervisors, and the company secretary, ensuring full representation [2][3] Group 2 - The following proposals were approved during the meeting: 1. 2024 Annual Board Work Report 2. 2024 Annual Supervisory Board Work Report 3. 2024 Financial Settlement Report 4. 2025 Financial Budget Report 5. 2024 Annual Report and its Summary 6. 2024 Profit Distribution and Capital Reserve Fund Conversion Plan 7. Reappointment of the accounting firm 8. 2025 Director Remuneration Plan 9. 2025 Supervisor Remuneration Plan 10. Application for comprehensive credit line from banks [3][4][5] - Separate voting was conducted for proposals 6, 7, and 8 to ensure the interests of minority investors were considered [5] Group 3 - The meeting was witnessed by Shanghai Guangfa Law Firm, confirming that the procedures followed were in compliance with relevant laws and regulations [5] - The legal representatives concluded that the meeting's convening and voting processes were valid and lawful [5]

Core Viewpoint - The human brain engineering sector experienced a slight increase of 0.47% on May 13, with a total capital outflow of 592.5 million [1] Group 1: Market Performance - The number of stocks that increased in value was 12, while 11 stocks saw a decline [1] - The top-performing stocks in the sector included Chengyitong (up 5.7%), Saily Medical (up 4.66%), and Aipeng Medical (up 3.6%) [1] - The stocks with the largest declines included *ST Shengxun (down 3.69%), ST Huaton (down 3.37%), and Yanshan Technology (down 2.51%) [1] Group 2: Capital Flow - The net capital inflow for the top-performing stock Chengyitong was 3.02 million, representing a net capital ratio of 8.44% [1] - Saily Medical had a net capital inflow of 31.18 million, with a net capital ratio of 9.10% [1] - In contrast, stocks like Lepu Medical and Keda Xunfei experienced net capital outflows of 0.75 million and 0.06 million, respectively [1]

据华为数据储存，华为在CHIMA2025上展示了其助力医疗行业数智化转型的最新成果。华为医疗卫生 军团总裁张伟力强调，AI技术将提升医疗服务效率和优化资源配置。华为推出DCS AI解决方案，通过 ModelEngine工具链、DCS XPU池化和AI数据湖等技术，解决AI应用面临的挑战，提升模型训练和推理 效率，缩短数据准备和应用开发周期。合作医院已显著缩短业务上线周期，提升医疗服务质量与患者体 验。华为持续构建AI生态，推动医疗行业数智化发展。 ...

智通财经5月13日电，午后贝瑞基因涨停，华大基因涨超15%，迪安诊断、安必平、嘉和美康、美年健 康、润达医疗等涨幅靠前。消息面上，OpenAI宣布推出了一个专门面向医疗大模型的测试评估集 —— HealthBench 并开源，旨在更好地衡量 AI 系统在医疗健康领域能力，为进一步推动AI医疗技术的发展 和应用做出重要贡献。 AI医疗概念震荡走强 贝瑞基因涨停 ...

天眼查App显示，近日，四川之江小象医疗科技有限公司成立，法定代表人为杨平号，注册资本1000万 人民币，由四川数智小象科技有限公司全资持股。 序号股东名称持股比例1四川数智小象科技有限公司100% 经营范围含技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广；信息系统集成服务；网 络与信息安全软件开发；移动终端设备销售；通讯设备销售；电子产品销售；物联网技术服务；信息技 术咨询服务；数据处理服务；国内贸易代理；货物进出口；智能控制系统集成；国内货物运输代理；卫 星移动通信终端销售；第一类医疗器械销售；医用口罩批发；医用口罩零售；医护人员防护用品批发； 医护人员防护用品零售；日用口罩（非医用）销售；劳动保护用品销售；特种劳动防护用品销售；第二 类医疗设备租赁；第一类医疗设备租赁；移动通信设备销售；健康咨询服务（不含诊疗服务）；计算机 及通讯设备租赁；计算机系统服务；软件销售；软件开发；数据处理和存储支持服务；仓储设备租赁服 务；普通货物仓储服务（不含危险化学品等需许可审批的项目）；技术进出口；第二类医疗器械销售； 护理机构服务（不含医疗服务）；人工智能基础软件开发；人工智能理论与算法软件开发；人工智能 ...

5月11日，第二十七届中国北京国际科技产业博览会（简称"北京科博会"）成功闭幕。以"科技引领创享未来"为主题，本届科博会设有信息科技、智能制 造、医药健康、绿色双碳、数字经济和区域创新6个专题展区，吸引了800余家中外企业和机构参展。 在本届北京科博会上，多项创新成果展出。其中，AI技术与医疗健康的深度融合成为亮点，智能手术机器人正助力提升基层医疗水平，更精准、稳定的疼 痛管理得以实现。我国医疗产业自主可控进展显著，部分企业实现全产业链国产化，另一些则在关键技术上突破国外垄断。"中国智造"不仅在国内大放异 彩，更在国际舞台上展现出强大的竞争力。 AI融入医疗健康：手术机器人加持基层医疗 疼痛管理更精准 北京科博会期间，多款融合了AI技术的创新医疗器械惊艳亮相。 亦庄展区内，强联智创(北京)科技有限公司的展位上，手术模拟器展示了在神经介入手术中，使用AI导管塑形机器人进行塑形后的微导管在脑血管模型中进 行模拟手术操作的过程。 北京科博会上，强联智创展出的导管塑形机器人。 强联智创董事长助理曾烨对贝壳财经记者介绍，神经介入手术在外科手术中难度极大，建立通路需对耗材进行预塑形，以往全靠医生凭经验想象完成，现在 手术 ...

申万宏源证券承销保荐有限责任公司 关于苏州麦迪斯顿医疗科技股份有限公司 保荐工作总结报告书 申万宏源证券承销保荐有限责任公司（以下简称"申万宏源承销保荐"、 "保 荐机构"）作为苏州麦迪斯顿医疗科技股份有限公司（以下简称"公司"或"麦 迪科技"）2022年非公开发行股票的保荐机构，持续督导期间为2023年1月3日至 券发行上市保荐业务管理办法》、《上海证券交易所上市公司自律监管指引第11 号——持续督导》、 《上海证券交易所股票上市规则》等相关法律法规文件要求， 申万宏源承销保荐现出具保荐工作总结报告书，具体内容如下： 一、保荐机构及保荐代表人承诺 误导性陈述或重大遗漏，保荐机构及保荐代表人对其真实性、准确性、完整性承 担法律责任。 进行的任何质询和调查。 理办法》及上海证券交易所（以下简称"上交所"）按照《上海证券交易所上市公 司自律监管指引第11号——持续督导》等有关规定采取的监管措施。 二、保荐机构基本情况 保荐机构名称 申万宏源证券承销保荐有限责任公司 新疆乌鲁木齐市高新区（新市区）北京南路358号大 注册地址 | | 成国际大厦20楼2004室 | | --- | --- | | 法定代表人 | 王 ...

Important Market News - The high-level economic and trade talks between China and the U.S. were held in Geneva from May 10 to 11, resulting in substantial progress and important consensus on mutual economic concerns [1] Industry Insights - On May 11, the humanoid robot startup Songyan Power launched a new generation of bionic robot named Xiao Nuo, featuring multi-modal interaction and near-human facial expressions. The company has already secured over 1,000 orders for its N2 robot, which has gained attention for its performance in various terrains [2] - The introduction of 5G-A technology is being noticed by consumers in cities like Beijing and Shanghai, enhancing communication capabilities significantly compared to 5G. The expected investment in 5G-A in China is projected to reach 120 billion yuan by 2025, driving growth in related industries [3] - A new online platform for "brain-computer interface patents and intellectual property" was launched at the 2025 Pujiang Innovation Forum, marking a significant step in the commercialization of brain-computer interface technology, with a market potential projected to reach $150 billion by 2040 [4] - The State Council approved the draft of the "Regulations on Government Data Sharing," aiming to enhance public service efficiency and promote the integration of data resources, which is expected to benefit cloud computing and big data platform companies [5][6] Risk Alerts - Xi'an Qujiang Cultural Tourism announced that its major shareholder's 12 million shares will be auctioned, representing 10.48% of its holdings and 4.7% of the company's total shares, although this will not affect the company's operations [7] - Keli Ke plans to reduce its shareholding by up to 14.647 million shares, accounting for 3% of the total shares, while other executives also plan to sell a small percentage of their shares [8]